Matt Okoneski brings broad life science industry experience to RCV and is a strong proponent of elevating the entrepreneurial ecosystem of Michigan across all industries through early-stage investment and company building.
Matt comes from the Michigan Biomedical Venture Fund, where he worked as an analyst and supported several investments in seed stage life science spinouts from the University of Michigan. Other experience includes project management at the U-M Coulter Translational Research Program and regulatory affairs at Medtronic.
Matt holds an MS in Medicinal Chemistry from the University of Michigan as well as a BS in Marine Biology and BA in Chemistry from the University of North Carolina Wilmington.